ClinicalTrials.Veeva

Menu

Validation of BodPod in Pediatric Anorexia Nervosa (PADAAM)

Civil Hospices of Lyon logo

Civil Hospices of Lyon

Status

Completed

Conditions

Anorexia Nervosa

Treatments

Other: Measure of body composition by Air Displacement Plethysmography (ADP)

Study type

Interventional

Funder types

Other

Identifiers

NCT04321317
69HCL20_0120

Details and patient eligibility

About

Anorexia nervosa is a severe cause of undernutrition. It leads to a dramatic decrease of weight with an important modification of the body composition. During the renutrition phase, disharmonious body composition recovery is a relapse factor. Dual X-ray absorptiometry (DXA) is the gold standard to study body composition in children with anorexia nervosa. But, due to technical limits, DXA analysis needs to take in account a potential failure to thrive with an adjustment on height. Moreover DXA needs an irradiation which does not allow close repeat measurements. Since several years, a simple, non-invasive, non-irradiant method for measure of body composition has been developed in pediatrics: the air displacement plethysmography (ADP). Actually, only one device is available for this measurement: the BodPod®. However, feasibility and accuracy of ADP compare to DXA have not been evaluated in pediatric anorexia nervosa. The aim of this study is to compare the accuracy of BodPod® compare to DXA in girls with anorexia nervosa.

Enrollment

10 patients

Sex

Female

Ages

8 to 18 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Female patients aged between 8 and 18 years
  • Female with a diagnosis of anorexia nervosa according to the DSM V classification, restrictive type or hyperphagic / purgative access type, evolving for less than 3 years.
  • Female who received explanations adapted to their level of understanding for this study
  • Female who expressed their consent to participate to this study
  • Female whose parents or holders of parental authority have been informed and signed free and informed consent
  • Female affiliated to a social security scheme

Exclusion criteria

  • Patients with psychotic symptoms
  • Patients with claustrophobia
  • Patients with severe respiratory disease

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

10 participants in 1 patient group

Undernourished Patients
Other group
Description:
All patients included will be included in the unique arm of the study
Treatment:
Other: Measure of body composition by Air Displacement Plethysmography (ADP)

Trial contacts and locations

1

Loading...

Central trial contact

Diane MORFIN, Dr

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems